NCT03542357View on ClinicalTrials.gov

The Effect of Sumatriptan and Placebo on CGRP Induced Headache

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 15, 2018

Primary Completion Date

September 1, 2018

Study Completion Date

September 1, 2018

Conditions
Migraine
Interventions
DRUG

Calcitonin Gene Related Peptide

CGRP is given both study days to induce headache. One day the headache is treated with placebo and the other day with sumatriptan

DRUG

Sumatriptan 50 mg

CGRP is given both study days to induce headache. One day the headache is treated with placebo and the other day with sumatriptan

DRUG

Placebo Oral Tablet

CGRPis given both study days to induce headache. One day the headache is treated with placebo and the other day with sumatriptan

Trial Locations (1)

2600

Rigshospitalet Glostrup, Glostrup Municipality

All Listed Sponsors
lead

Danish Headache Center

OTHER

NCT03542357 - The Effect of Sumatriptan and Placebo on CGRP Induced Headache | Biotech Hunter | Biotech Hunter